ARTICLE | Finance
Paper chase
Through 3Q18 NASDAQ biotech IPOs on track to beat 2015’s record
September 28, 2018 11:56 PM UTC
Even before this week’s spate of IPOs, this year’s class of newly public biotechs on NASDAQ had surpassed that of 2017 in terms of funds raised, leaving this year’s class within striking distance of 2015’s record.
The first three quarters of 2018 saw 48 biotechs raise $4.7 billion in IPOs on NASDAQ, versus the $3.5 billion raised by 37 biotechs on NASDAQ all of last year. ...